CDC42 and oropharynx squamous cell carcinoma: In the context of recurrent or metastatic oropharyngeal squamous cell carcinoma (OSCC, a form of HNSCC), CDC42 partakes in the pathologic and progressive aspects of the disease by modulating malignant tumor behavior and immune evasion (Chen, Chen & Liu, 2024).